Artrya (ASX:AYA)
ASX announcement history & article coverage
Transparent by design.
Announcments by Artrya (ASX:AYA) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
FY26 Financial Results and Operational Update Presentation
Artrya reports FY26 results with commercial launch, $80M capital raise, and FDA clearance progress
Application for quotation of securities - AYA
Issue of Shares on Exercise of Securities &Cleansing Notice
Application for quotation of securities - AYA
Issue of Shares on Exercise of Securities & Cleansing Notice
Appointment of Non-Executive Director - Helen Kurincic
Appendix 4G
Corporate Governance Statement
Appendix 4E and Annual Report to Shareholders
Artrya reports FY2026 loss of $25.18m, advances US commercial rollout with FDA clearances and $80m capital raise
Ceasing to be a substantial holder
June Quarterly Activities Report and Appendix 4C
Artrya advances U.S. commercial rollout and FDA submission with $74M cash position
Northeast Georgia Health System goes live with Salix
Artrya's Salix® Platform Goes Live at Northeast Georgia Health System, Begins Revenue Generation
Notification of cessation of securities - AYA
Change of Director's Interest Notice - B Ridgeway
Notification of cessation of securities - AYA
Notification regarding unquoted securities - AYA
Becoming a substantial holder
Application for quotation of securities - AYA
Share Issue and Cleansing Notice
Change of Director's Interest Notice - B Ridgeway
Application for quotation of securities - AYA
Issue of Shares and Cleansing Notice
Change of Director Interests Notice
Sale of Shares to Fund Options Exercise
Application for quotation of securities - AYA
Issue of Shares and Cleansing Notice